The present invention relates generally to mass spectrometers and in particular to spectrometers that are configured to fragment precursor ions to form fragment ions.
It is known in mass spectrometry to fragment precursor ions to produce fragment ions. For example, high energy (unstable) molecular ions formed in the ionisation source of a mass spectrometer may be subsequently fragmented. The fragment ions may be mass analysed so as to produce a pattern in the mass spectrum that can then be used to determine structural information of the precursor.
It is known to fragment ions using a number of different techniques. The fragmentation is usually performed in a dedicated fragmentation cell that is located within a low pressure vacuum chamber of the mass spectrometer. For example, a collision-induced-dissociation (CID) fragmentation cell may be arranged in the vacuum chamber, in which arrangement the fragmentation cell has a dedicated collision gas supply. Precursor ions are then accelerated into the collision gas, causing them to dissociate into fragment ions.
CID fragmentation is known to occur as ions are transferred from the ion source to the vacuum region of the mass spectrometer, since the ions pass through a relatively high pressure region. Such fragmentation is, however, generally not desired as it interferes with the post-source fragmentation within the collision cell(s) arranged in the vacuum chamber of the mass spectrometer and complicates the data processing and data interpretation. Therefore, the ion source conditions are tuned so as to minimise this type of fragmentation.
From a first aspect the present invention provides a mass spectrometer comprising: a first vacuum chamber having an inlet aperture; a second vacuum chamber adjacent the first vacuum chamber; a differential pumping aperture separating the first and second vacuum chambers; an ion guide arranged in the first vacuum chamber for guiding ions from the inlet aperture to and through the differential pumping aperture, wherein the ion guide comprises a first portion configured to guide ions along a first axial path, a second portion configured to guide ions along a second different axial path, and a transition portion configured to urge ions from the first axial path onto the second axial path; and a voltage supply arranged and configured to apply voltages to electrodes in the spectrometer so as to accelerate ions through the first vacuum chamber; wherein the spectrometer is configured to operate in a first mode in which it maintains the gas pressure in the first vacuum chamber such that when the voltage supply causes ions to be accelerated the ions collide with gas in the first vacuum chamber and fragment to form fragment ions.
The form of the spectrometer, particularly the ion guide, allows for high gas loads to be handled in the first vacuum chamber and that the resulting increase in gas pressure may be used to fragment ions efficiently. The form of the ion guide and its arrangement within the spectrometer are therefore synergistic with the fragmentation technique described herein.
More specifically, the arrangement of the ion guide in a first of the two vacuum chambers (i.e. two-stage vacuum pumping), together with the form of the ion guide, enables the spectrometer to handle high gas loads entering the inlet aperture. As such, a relatively large inlet aperture may be provided, enabling a relatively high proportion of the ions from an ion source to enter the inlet aperture for subsequent analysis. The ion transmission rate through the first vacuum chamber may consequently be relatively high (e.g. a factor of 25 higher) as compared to instruments having conventional multipole ion guides in the first vacuum chamber. This enables the embodiments to have a relatively high sensitivity. Although a large inlet aperture would conventionally provide high chemical noise and be seen as undesirable, the ion guide of the embodiments of the present invention enables a high gas pressure and hence improved fragmentation, whilst also providing a good signal-to-noise ratio. The high signal-to-noise ratio is provided as the embodiments are able to separate neutral species and/or large cluster species from the analyte ions. More specifically, the ions are transferred from the first axial path of the ion guide to the second axial path of the ion guide, whereas the neutral species and/or large cluster species may continue along the first axial path. The ion guide therefore enables the ions to be onwardly transmitted into the second vacuum chamber and for the neutral species and/or large cluster species not to be. For example, the neutral species and/or large cluster species may be pumped away by the vacuum pump.
Although the form of the ion guide is known, it has previously been used for focussing a relatively diffuse ion cloud into the mass spectrometer (by using an ion guide having a radially larger first portion than the second portion). In such ion uses it has not been recognised that such an ion guide can handle higher gas loads and so is synergistic with the fragmentation technique described herein. In contrast, in these known techniques the operational conditions are selected such that the ions are collisionally cooled by the background gas such that they are better able to be focussed, i.e. the average energy of the ions is reduced. This is contrary to the techniques described herein, which deliberately increase the energy of the ions by accelerating them through the gas so as to cause them to fragment.
This form of the ion guide may alternatively have been contemplated for use in various ion manipulation devices (for transferring ions between axial paths). However, as described above, the synergy between the high gas load that the ion guide is able to handle and CID fragmentation has not previously been recognised in such techniques. Therefore, it has not been contemplated in such techniques to provide the ion guide in a first vacuum chamber that is upstream of a second (lower pressure) vacuum chamber, whilst also performing CID fragmentation in the first vacuum chamber. In contrast, in these conventional instruments having collision cells for fragmenting ions, the operating parameters are configured so as to avoid fragmentation in such a first vacuum chamber, which would otherwise complicate the data analysis of the fragment ions generated in the downstream collision cell.
The embodiments of the invention enable fragmentation in the ion guide in the first vacuum chamber. In contrast, conventional instruments provide a fragmentation cell in the lower pressure regions downstream of the first vacuum chamber, which then requires a dedicated gas supply to the fragmentation cell in order to provide the required gas pressure for CID fragmentation.
Furthermore, as the ion guide of the embodiments of the present invention enables a high gas pressure in the first vacuum chamber, the gas pressure may be significantly higher than the traditional dedicated fragmentation cells mentioned above. Therefore, the embodiments provide for more efficient fragmentation of molecular ions than traditional fragmentation cells.
According to embodiments of the present invention, the fragment ions may be generated in the first and/or second portions of the ion guide, and/or in the transition portion of the ion guide, and are transmitted by the ion guide to the differential pumping aperture.
The spectrometer may be configured to maintain the first vacuum chamber at a gas pressure selected from: ≥0.01 mBar; ≥0.05 mBar; ≥0.1 mBar; ≥0.2 mBar; ≥0.3 mBar; ≥0.4 mBar; ≥0.5 mBar; ≥0.6 mBar; ≥0.7 mBar; ≥0.8 mBar; ≥0.9 mBar; ≥1 mBar; ≥1.2 mBar; ≥1.4 mBar; ≥1.6 mBar; ≥1.8 mBar; or ≥2 mBar. The preferred range may be 1-2 mBar.
Said voltage supply may be configured to generate a DC static voltage gradient in the first vacuum chamber for accelerating ions to fragment.
The voltage gradient may be substantially along the first and/or second axial path.
The voltage gradient may be formed by applying different voltages to at least the upstream and downstream electrodes of the ion guide. Different voltages may be applied to all of the different axial sections of the ion guide so as to form the voltage gradient.
The voltage gradient may be varied with time, e.g. to optimise fragmentation for different types of ions (e.g. having different molecular sizes and/or structures). This may be varied during a single experimental run or between different experimental runs. For example, for experiments such as peptide mapping experiments there are many different types of molecules in a single sample and therefore a range of voltage gradients may be applied in a single experimental run. The voltage may be incremented in steps to affect the voltage gradient, e.g. by a unit of one volt at a time.
The voltage gradient may be repeatedly scanned or stepped during a single experimental run. The voltage gradient may be scanned or stepped over the same range, or different ranges. For example, the voltage gradient may be scanned or stepped over a range at a rate of between 0.2 Hz and 20 Hz. In the example in which the rate is 0.2 Hz the voltage gradient will be scanned or stepped across the range in 5 second, whilst at 20 Hz the scanning or stepping will take 0.05 seconds.
The potential drop of the voltage gradient at any given time may be between 60-150 V. However, other voltage drops are contemplated such as 50-160 V, 40-170 V, 30-180 V, 20-190 V or 10-200 V. The voltage drop may be selected (e.g. automatically by the spectrometer) based on user input identifying target ions to be fragmented.
Alternatively, or additionally, the voltage supply may be configured to travel one or more potential barrier (e.g. DC barrier) along the first and/or second ion guide portion so as to urge the ions to collide with the gas and fragment. This may be performed by successively applying one or more transient DC voltage to successive electrodes along the ion guide. The one or more DC potential barrier may be repeatedly travelled along the ion guide. The one or more DC potential barrier may be travelled along the ion guide in a direction from the inlet to the differential pumping aperture of the first vacuum chamber, or from the differential pumping aperture to the inlet of the first vacuum chamber (e.g. opposing the gas flow to cause higher collision energies).
The inlet aperture may separate the first vacuum chamber from a region that is at higher pressure than the first vacuum chamber, in use. Said region may be an atmospheric pressure region and the inlet aperture may be an atmospheric pressure interface.
The spectrometer may comprise a source of ions in the said region that is at higher pressure than the first vacuum chamber. Said source of ions may be an atmospheric pressure ion source.
The inlet aperture may have a diameter of: ≥0.5 mm; ≥0.55 mm; ≥0.6 mm; ≥0.65 mm; ≥0.7 mm; ≥0.75 mm; ≥0.8 mm; ≥0.85 mm; ≥0.9 mm; ≥0.95 mm; or ≥1 mm.
The ion guide enables a high gas load in the first vacuum chamber and so a relatively large inlet aperture is able to be used, enabling an increased ion transmission through the inlet aperture and into the first vacuum chamber.
A central axis of the first axial path of the ion guide may pass through said inlet aperture and/or a central axis of the first axial path of the ion guide may be coaxial with a central axis said inlet aperture.
A central axis of the second axial path of the ion guide may pass through said differential pumping aperture and/or a central axis of the second axial path of the ion guide may be coaxial with a central axis said differential pumping aperture.
The first vacuum chamber may further comprise a gas pumping port for evacuating the first vacuum chamber of gas, and at least part of the second portion of the ion guide may be shielded from the gas pumping port by a barrier.
The barrier may be configured such that the majority of the gas flow through the first vacuum chamber passes from said inlet aperture to the gas pumping port without passing through said at least part of the second portion of the ion guide.
The first vacuum chamber may comprise a gas pumping port for evacuating the first vacuum chamber of gas, and a central axis of the first axial path of the ion guide may pass through said gas pumping port and/or a central axis of the first axial path of the ion guide may be coaxial with a central axis said gas pumping port.
The first portion of the ion guide may have a larger radial cross-section than the second portion of the ion guide.
The ion guide may be configured such that the first axial path of the ion guide is substantially parallel to and displaced from the second axial path of the ion guide.
The first and/or second portion of the ion guide may comprise a plurality of electrodes, wherein the plurality of electrodes are axially spaced electrodes and each electrode is an electrode having an aperture through which ions are transmitted in use. However, it is contemplated that other electrodes may be used, such as multipole or plate electrodes.
The transition portion of the ion guide may comprise: at least one first electrode, each of which only partially surrounds the first axial path and has a radial opening in its side that is directed towards the second axial path; at least one second electrode, each of which only partially surrounds the second axial path and has a radial opening in its side that is directed towards the first axial path; and electrodes for providing a potential difference so as to urge ions in the direction from the first axial path to the second axial path.
The spectrometer may comprise one or more RF voltage supply for supplying RF voltages to the electrodes of the first and/or second portions of the ion guide, and/or to the transition portion of the ion guide, for radially confining ions within these portions.
Different phases of an RF voltage may be applied to axially adjacent electrodes in each portion, e.g. opposite phases.
The spectrometer may comprise a mass and/or ion mobility analyser in the second vacuum chamber or in a further vacuum chamber downstream of the second vacuum chamber.
The spectrometer is configured to pump the second vacuum chamber to a lower pressure than the first vacuum chamber. If said further vacuum chamber is provided, a differential pumping aperture is provided that separates the second vacuum chamber from the further vacuum chamber, and the spectrometer is configured to pump the further vacuum chamber to a lower pressure than the second vacuum chamber.
The mass analyser may be a Time of Flight mass analyser.
The mass spectrometer may be configured to operate in a second mode in which the pressure in the first vacuum chamber and said voltage supply are controlled such that ions are fragmented at a substantially lower rate than in the first mode. For example, substantially no ions may be fragmented in the second mode.
The pressure in the first vacuum chamber may be maintained the same in the first and second modes, or the pressure may be higher in the first mode than the second mode.
The voltage supply may be configured to change the voltages supplied to the electrodes between the first and second modes such that ions are accelerated at a higher rate in the first mode than in the second mode.
The spectrometer may be configured to alternate between the first and second modes, e.g. during a single experimental run.
The spectrometer may be configured to mass analyse fragment ions in the first mode, mass analyse precursor ions in second mode, and correlate the fragment ions analysed in the first mode with their respective precursor ions analysed in the second mode.
The method may correlate the fragment ions analysed in the first mode with their respective precursor ions analysed in the second mode by: (i) matching the ion signal intensity profiles of fragment ions (as a function of time) with ion signal intensity profiles of precursor ions (as a function of time); and/or (ii) matching the fragment ions to their precursor ions based on the times at which the fragment and precursor ions are detected (e.g. based on the detected elution times of the ions in the experiment(s)).
The present invention also provides a method of mass spectrometry comprising:
providing a mass spectrometer as described above; transmitting ions through said inlet aperture into said ion guide; guiding ions through said ion guide along said first axial path, through said transition portion and along said second axial path to said differential pumping aperture;
operating the spectrometer in the first mode in which the pressure in the first vacuum chamber and said voltage supply are controlled such that ions are accelerated by the voltage supply so as to collide with gas in the first vacuum chamber and fragment to form fragment ions.
The first vacuum chamber is pumped to a first pressure and the second vacuum chamber may be pumped to a second, lower pressure.
The inlet aperture may separate the first vacuum chamber from a region that is at higher pressure than the first vacuum chamber.
The method may comprise evacuating gas from the first vacuum chamber through a gas pumping port, wherein at least part of the second portion of the ion guide is shielded from the gas pumping port by a barrier so that the majority of the gas flow through the first vacuum chamber passes from said inlet aperture to the gas pumping port without passing through said at least part of the second portion of the ion guide.
The method may comprise mass and/or ion mobility analysing ions in the second vacuum chamber or in a further vacuum chamber downstream of the second vacuum chamber.
The method may comprise operating the spectrometer in a second mode in which the pressure in the first vacuum chamber and said voltage supply are controlled such that ions are fragmented at a substantially lower rate than in the first mode. For example, substantially no ions may be fragmented in the second mode.
The pressure in the first vacuum chamber may be maintained the same in the first and second modes, or the pressure may be higher in the first mode than the second mode.
The voltage supply may change the voltages supplied to the electrodes between the first and second modes such that ions are accelerated at a higher rate in the first mode than in the second mode.
The method may comprise alternating between the first and second modes, e.g. during a single experimental run.
The method may comprise mass analysing fragment ions in the first mode, mass analysing precursor ions in second mode, and correlating the fragment ions analysed in the first mode with their respective precursor ions analysed in the second mode.
The method may correlate the fragment ions analysed in the first mode with their respective precursor ions analysed in the second mode by: (i) matching the ion signal intensity profiles of fragment ions with ion signal intensity profiles of precursor ions; and/or (ii) matching the fragment ions to their precursor ions based on the times at which the fragment and precursor ions are detected.
Embodiments of the present invention provide a method of identifying biomolecules using the above-described method of mass spectrometry. Ions of the biomolecules are transmitted through the inlet aperture, into the ion guide and are accelerated by the voltage supply so as to collide with gas in the first vacuum chamber and fragment to form the fragment ions.
The biomolecules may be peptides.
The method may comprise identifying the peptides by peptide mapping.
The peptide mapping may comprise: mass analysing the fragment ions; comparing the resulting first mass spectral data to a database, wherein the database includes a plurality of peptides that are each associated with second mass spectral data for a plurality of fragment ions of that peptide; determining that said first mass spectral data matches said second mass spectral data for one of said peptides in the database; and identifying that peptide as a peptide that has been mass analysed by the mass spectrometer.
The method may comprise digesting a protein or peptide and ionising the resulting peptides so as to form peptide ions, and then transmitting the peptide ions through said inlet aperture.
The protein or peptide may be tryptically digested, or digested with a different enzyme.
The method may comprise digesting a monoclonal antibody and ionising the resulting peptides so as to form peptide ions, and then transmitting peptide ions through said inlet aperture.
The method may comprise separating said resulting peptides before the step of ionising the peptides so that ions of different peptides are transmitted into the ion guide at different times.
The peptides may be separated by liquid chromatography.
The voltage supply may generate a DC voltage gradient in the first vacuum chamber that accelerates the ions to fragment them into said fragment ions; wherein a range of different DC voltage gradients are provided during a single experimental run.
The techniques described herein may increase the fragmentation efficiency and sensitivity, for example, for biomolecules to aid biotherapeutics characterization and critical quality attributes (CQAs) monitoring.
Accordingly, the present invention also provides a method of biotherapeutics characterisation comprising: (i) providing a mass spectrometer comprising: a first vacuum chamber having an inlet aperture; a second vacuum chamber adjacent the first vacuum chamber; a differential pumping aperture separating the first and second vacuum chambers; an ion guide arranged in the first vacuum chamber for guiding ions from the inlet aperture to and through the differential pumping aperture, wherein the ion guide comprises a first portion configured to guide ions along a first axial path, a second portion configured to guide ions along a second different axial path, and a transition portion configured to urge ions from the first axial path onto the second axial path; and a voltage supply arranged and configured to apply voltages to electrodes in the spectrometer so as to accelerate ions through the first vacuum chamber; (ii) transmitting ions through said inlet aperture into said ion guide; (iii) guiding ions through said ion guide along said first axial path, through said transition portion and along said second axial path to said differential pumping aperture; and (iv) operating the spectrometer in the first mode in which the pressure in the first vacuum chamber and said voltage supply are controlled such that the ions are accelerated by the voltage supply so as to collide with gas in the first vacuum chamber and fragment to form fragment ions.
Various embodiments will now be described, by way of example only, and with reference to the accompanying drawings in which:
In mass spectrometry, analyte ions are often generated by relatively high pressure ion sources, e.g. by atmospheric pressure ion sources. It is then necessary to transmit these ions into a vacuum region of the mass spectrometer, since the processing or analysis of the ions is required to be performed at relatively low vacuum pressures.
In operation, the intermediate pressure chamber 8 is pumped to a lower pressure than the atmospheric pressure region 4, and the vacuum chamber 6 is pumped to a lower pressure than the intermediate pressure chamber 8. Analyte solution is then delivered to the capillary 16 of the ESI probe 2 and is sprayed from the tip thereof so as to produce analyte ions 18 in the atmospheric pressure region 4. The analyte ions 18 then pass through the cone 10 and into the ion guide 14 in the intermediate pressure chamber 8. The ion guide 14 guides the ions through the intermediate pressure chamber and through the differential pumping aperture 12 into the vacuum chamber 6. The ions may then be fragmented in the vacuum chamber 6, or in a further downstream vacuum chamber of the spectrometer which may be pumped to an even lower pressure.
In the embodiment of
The ion guide comprises a first portion 30 for guiding ions along a first axial path, a second portion 32 for guiding ions along a second axial path (which may be parallel to and displaced the first axial path), and a transition portion 33 for transferring ions from the first axial path to the second axial path. In the depicted embodiment, each of the first and second ion guide portions 20,32 comprises a plurality of axially separated apertured electrodes (e.g. ring electrodes) for radially confining the ions along their respective axial paths. RF voltages are applied to these electrodes so as to radially confine the ions. For example, different (e.g. opposite) phases of an RF voltage supply may be applied to adjacent apertured electrodes in the known manner so as to radially confine the ions.
Referring back to
A vacuum pump is provided for evacuating the first vacuum chamber 24 through a gas pumping port 38. The opening of the gas pumping port 38 may be aligned (e.g. coaxial) with the first axial path of the first ion guide portion 30. The end of the ion guide formed by the second portion 32 may be physically shielded from the gas pumping port 38 by a barrier 40.
In operation, ions are generated in high pressure region 22. The pressure differential between the high pressure region 22 and the first vacuum chamber 24 causes gas and ions to pass through the cone 20 and into the first vacuum chamber 24, whereby the gas and ions tend to expand into the lower pressure region. The ions enter into the first portion 30 of the ion guide and are radially confined thereby, but may be relatively diffuse, as shown by ion cloud 42. The ions are driven axially along the first portion 32 of the ion guide, at least partially by the gas flow towards the gas pumping port 38. When ions reach the transition portion 33 of the ion guide, they are urged in the radial direction and onto the second axial path defined by the second portion 32 of the ion guide, as shown by ion trajectories 43. As described above, this may be caused by applying a potential difference in the radial direction. As a result, ions are caused to migrate from the first ion guide portion 30 to the second ion guide portion 32. In contrast, the majority of the gas flow continues substantially along the axis defined by the first ion guide portion 30 towards and through the gas pumping port 38, as shown by arrow 44. Ions are therefore radially confined in the second ion guide portion 32 and travel along the second axial path towards the differential pumping aperture 26, whereas the majority of the gas is routed in a different direction towards the gas pumping port 38. At least part of the second portion 32 of the ion guide may be shielded from the pumping port by a barrier 40, so that the gas flow towards the pumping port 38 is directed away from the second axial path of the second ion guide portion 32.
The second ion guide portion 32 may have a smaller radial cross-section than the first portion 30 so that the ions are radially compressed in the second portion as compared to the first portion, as shown by ion beam 46. Ions are then guided by the second ion guide portion 32 through the differential pumping aperture 26 and into the second vacuum chamber 28.
Ion guides of the type described above are known for converting a diffuse ion cloud into a more compact ion cloud. However, the inventors have recognised that the ion guide in the above-described arrangement is able to handle relatively high gas loads (e.g. since the ion guide initially conveys the ions with the gas flow towards the pumping port and then moves the ions out of the gas flow), and that the ion guide therefore enables the first vacuum chamber 24 to be operated at relatively high pressures such that efficient CID fragmentation may be performed in this region.
Embodiments of the invention therefore accelerate the ions through the gas in the first vacuum chamber 24 so as to cause collisions between the ions and the gas molecules (and other species) that result in CID fragmentation of the precursor ions to form fragment ions. The precursor ions may be accelerated through the gas by a static DC electric field. For example, a DC voltage gradient may be arranged between a point in the first vacuum chamber 24 towards the cone 20 and a point towards the differential pumping aperture 26, e.g. by applying different DC voltages to these elements and/or to electrodes of the ion guide. The DC voltage gradient may be arranged along the first and/or second axis of the ion guide (and/or the transition region 33), e.g. by applying different voltages to electrodes of the ion guide at different axial locations. Alternatively, or additionally, ions may be accelerated into CID fragmentation with the gas by travelling one or more DC potential barrier along the first and/or second ion guide portions 30,32 so as to urge the ions to collide with the gas molecules. This may be performed by successively applying one or more transient DC voltage to successive electrodes along the ion guide. The one or more DC potential barrier may be repeatedly travelled along the ion guide. The one or more DC potential barrier may be travelled along the ion guide in a direction from the ion entrance (cone 20) to the ion exit (differential pumping aperture 26) of the first vacuum chamber 24, or from the ion exit to the ion entrance of the first vacuum chamber 24 (i.e. opposing the gas flow to cause higher collision energies).
As described above, the embodiments allow the handling of large gas loads into the instrument, enabling the use of a relatively large sampling cone 20 to capture significantly more ions from the upstream high pressure region 22. For example, the sampling cone 20 may have a diameter of about 0.8 mm. The ion transmission into the instrument and signal to noise ratio of the instrument are therefore improved. For example, the ion transmission may be increased by a factor of at least 25 and the signal to noise ratio may be increased by a factor of at least 5, as compared to arrangements having conventional multipole ion guides.
The embodiments provide increased collisions of the ions with the gas molecules due to the high gas load, enabling a high sequence coverage of analytes. For example, close to 100% sequence coverage was obtained in a monoclonal antibody (mAb) tryptically digested peptide mapping LC-MS experiment.
By way of example only, LC-MS and LC-MS/MS experiments for NIST mAb tryptically digested peptide mapping will now be described. NIST monoclonal antibody Reference Material 8671 (NIST mAb) was reduced and tryptically digested, lyophilized. The contents of one vial were reconstituted in water before injection. Analyses of this sample were performed using a Waters ACQUITY UPLC H-Class Bio LC system coupled to a single stage orthogonal acceleration TOF system (i.e. in which a TOF mass analyser is located in the second vacuum chamber). The separation method and the mass spectrometry conditions are outlined below.
LC Conditions:
Columns: ACQUITY UPLC Peptide BEH C18 Column, 300 Å, 1.7 μm, 2.1 mm×100 mm
Mobile Phase A: 0.1% (w/v) Formic acid in water
Mobile Phase B: 0.1% (w/v) Formic acid in acetonitrile
Column Temperature: 60° C.
Injection Volume: 2 μL
Sample Concentration: 0.2 μg/μL
Sample Diluent: water
UV Detection: 214 nm (20 Hz)
Gradient Table:
The experiment shows that fragmentation is performed more efficiently than in arrangements having conventional multipole ion guides, and the technique therefore produces fragments that have close to 100% sequence matching coverage (e.g. for 150 KDa monoclonal antibody molecules).
Although a specific example has been described above, the techniques described herein are applicable to the fragmentation of other species and forms of molecules. For example, embodiments are contemplated wherein the fragmentation and analysis of small pharmaceutical drugs, pesticides in food, environmental contaminants, or other biological molecules (such as lipids and oligonucleotides, synthetic polymers, etc.) are performed.
Although the present invention has been described with reference to preferred embodiments, it will be understood by those skilled in the art that various changes in form and detail may be made without departing from the scope of the invention as set forth in the accompanying claims.
For example, although the embodiments described above include an ion guide having two conjoined ion guide portions comprising ring electrodes, other embodiments are contemplated.
This application claims priority from and the benefit of U.S. Patent Application No. 62/678,413 filed on May 31, 2018. The entire content of this application is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2901622 | Baldwin | Aug 1959 | A |
4314156 | Kuppermann et al. | Feb 1982 | A |
4458149 | Muga | Jul 1984 | A |
5025391 | Filby et al. | Jun 1991 | A |
5593123 | Crawford | Jan 1997 | A |
5756994 | Bajic | May 1998 | A |
5776216 | Yang | Jul 1998 | A |
5825025 | Kerley | Oct 1998 | A |
5933335 | Hitchcock et al. | Aug 1999 | A |
6013913 | Hanson | Jan 2000 | A |
6049077 | Franzen | Apr 2000 | A |
6106223 | Leyshon | Aug 2000 | A |
6248998 | Okumoto et al. | Jun 2001 | B1 |
6316768 | Rockwood et al. | Nov 2001 | B1 |
6502999 | Cohen et al. | Jan 2003 | B1 |
6527458 | Kim | Mar 2003 | B2 |
6566653 | Gerber et al. | May 2003 | B1 |
6643075 | Wang et al. | Nov 2003 | B2 |
6663294 | Crane, Jr. et al. | Dec 2003 | B2 |
6712528 | Galeotti et al. | Mar 2004 | B2 |
6772649 | Zimmermann et al. | Aug 2004 | B2 |
6792171 | Hargis et al. | Sep 2004 | B2 |
6824314 | Bendelli et al. | Nov 2004 | B2 |
6835928 | Bateman | Dec 2004 | B2 |
6847036 | Darling et al. | Jan 2005 | B1 |
6862378 | Kamacewicz et al. | Mar 2005 | B2 |
6869231 | Chiu et al. | Mar 2005 | B2 |
6877912 | Cho et al. | Apr 2005 | B2 |
6888129 | Bowdler et al. | May 2005 | B2 |
6888860 | Shaw | May 2005 | B2 |
6903332 | Weiss et al. | Jun 2005 | B2 |
6956205 | Park | Oct 2005 | B2 |
6977369 | Yamaguchi et al. | Dec 2005 | B2 |
7019285 | Dresch et al. | Mar 2006 | B2 |
7129163 | Sherrer et al. | Oct 2006 | B2 |
7149389 | Yoon et al. | Dec 2006 | B2 |
7211794 | Malek et al. | May 2007 | B2 |
7247847 | Webb et al. | Jul 2007 | B2 |
7309861 | Brown et al. | Dec 2007 | B2 |
7322754 | Wolf et al. | Jan 2008 | B2 |
7359642 | Richardson et al. | Apr 2008 | B2 |
7372021 | Cotter et al. | May 2008 | B2 |
7375318 | Kikuma et al. | May 2008 | B2 |
7550722 | Scheidemann et al. | Jun 2009 | B2 |
7597488 | Fisher | Oct 2009 | B2 |
7622711 | Wildgoose et al. | Nov 2009 | B2 |
7645986 | Kikuma et al. | Jan 2010 | B2 |
7786435 | Whitehouse et al. | Aug 2010 | B2 |
7812309 | Guevremont et al. | Oct 2010 | B2 |
7820980 | Balogh | Oct 2010 | B2 |
7825374 | Cotter et al. | Nov 2010 | B2 |
7829841 | Bateman et al. | Nov 2010 | B2 |
7888630 | Wong | Feb 2011 | B2 |
7893401 | Ding | Feb 2011 | B2 |
7919747 | Green et al. | Apr 2011 | B2 |
7960694 | Hoyes | Jun 2011 | B2 |
8138119 | Fischer et al. | Mar 2012 | B2 |
8153960 | Giles et al. | Apr 2012 | B2 |
8183524 | Kenny et al. | May 2012 | B2 |
8227749 | Alonso | Jul 2012 | B2 |
8253096 | Numata | Aug 2012 | B2 |
8357892 | Suyama et al. | Jan 2013 | B2 |
8426802 | Giles et al. | Apr 2013 | B2 |
8507849 | Brown | Aug 2013 | B2 |
8513597 | Panayi | Aug 2013 | B2 |
8552367 | Danel et al. | Oct 2013 | B2 |
8637810 | Mukaibatake et al. | Jan 2014 | B2 |
8653452 | Albeanu et al. | Feb 2014 | B2 |
8704172 | Baykut | Apr 2014 | B2 |
8716660 | Green et al. | May 2014 | B2 |
8742339 | Hoyes | Jun 2014 | B2 |
8822915 | Mukaibatake et al. | Sep 2014 | B2 |
8927928 | Decker et al. | Jan 2015 | B2 |
8975578 | Green et al. | Mar 2015 | B2 |
9012840 | Bateman et al. | Apr 2015 | B2 |
9048075 | Kodera | Jun 2015 | B1 |
9058968 | Danel et al. | Jun 2015 | B2 |
9105456 | Jiang et al. | Aug 2015 | B2 |
9184039 | Pringle et al. | Nov 2015 | B2 |
9196469 | Makarov | Nov 2015 | B2 |
9281171 | Bateman et al. | Mar 2016 | B2 |
9287100 | Szalay et al. | Mar 2016 | B2 |
9318309 | Brown et al. | Apr 2016 | B2 |
9355832 | Chiappetta et al. | May 2016 | B2 |
9466472 | Bateman et al. | Oct 2016 | B2 |
9536721 | Berdnikov et al. | Jan 2017 | B2 |
9536727 | Satoh | Jan 2017 | B2 |
9552975 | Brown et al. | Jan 2017 | B2 |
9564307 | Makarov | Feb 2017 | B2 |
9601323 | Nishiguchi et al. | Mar 2017 | B2 |
9607820 | Bateman et al. | Mar 2017 | B2 |
9754773 | Gonzalez et al. | Sep 2017 | B1 |
9768008 | Verenchikov | Sep 2017 | B2 |
9812308 | Berdnikov et al. | Nov 2017 | B2 |
9859106 | Chiappetta et al. | Jan 2018 | B2 |
9865444 | Okumura | Jan 2018 | B2 |
9870904 | Covey et al. | Jan 2018 | B2 |
9870906 | Quarmby et al. | Jan 2018 | B1 |
9880129 | Bateman | Jan 2018 | B2 |
9939407 | Giles et al. | Apr 2018 | B2 |
9978572 | Giles et al. | May 2018 | B2 |
9984861 | Giles et al. | May 2018 | B2 |
9984863 | Verenchikov | May 2018 | B2 |
10014167 | Zhang et al. | Jul 2018 | B2 |
10020181 | Okumura | Jul 2018 | B2 |
20010017351 | Terakura | Aug 2001 | A1 |
20010030284 | Dresch et al. | Oct 2001 | A1 |
20020100870 | Whitehouse et al. | Aug 2002 | A1 |
20020131724 | Bailey et al. | Sep 2002 | A1 |
20030003595 | Amirav | Jan 2003 | A1 |
20030027354 | Geli | Feb 2003 | A1 |
20030193019 | Nagano et al. | Oct 2003 | A1 |
20040089803 | Foley | May 2004 | A1 |
20050213353 | Lys | Sep 2005 | A1 |
20060076483 | Scheidemann et al. | Apr 2006 | A1 |
20060219891 | Balogh | Oct 2006 | A1 |
20060237663 | Balogh | Oct 2006 | A1 |
20070164209 | Balogh | Jul 2007 | A1 |
20080087841 | Verbeck et al. | Apr 2008 | A1 |
20080149825 | Kozlovski et al. | Jun 2008 | A1 |
20090101814 | Amirav | Apr 2009 | A1 |
20090179148 | Yasuda et al. | Jul 2009 | A1 |
20100243887 | Suyama et al. | Sep 2010 | A1 |
20110127416 | Campuzano et al. | Jun 2011 | A1 |
20110174969 | Seyfarth | Jul 2011 | A1 |
20110220786 | Satoh | Sep 2011 | A1 |
20120068064 | Numata | Mar 2012 | A1 |
20120085901 | Gilbert et al. | Apr 2012 | A1 |
20120205534 | Hunter et al. | Aug 2012 | A1 |
20130183355 | Jain et al. | Jul 2013 | A1 |
20140183355 | Bartfay-Szabo et al. | Jul 2014 | A1 |
20140346345 | Makarov | Nov 2014 | A1 |
20140367563 | Zhong et al. | Dec 2014 | A1 |
20150076338 | Young et al. | Mar 2015 | A1 |
20150123354 | Laser et al. | May 2015 | A1 |
20150263642 | Lin et al. | Sep 2015 | A1 |
20150323500 | Davis et al. | Nov 2015 | A1 |
20160148796 | Makarov | May 2016 | A1 |
20160155620 | Makarov | Jun 2016 | A1 |
20160172179 | Deerberg et al. | Jun 2016 | A1 |
20160203967 | Atkinson et al. | Jul 2016 | A1 |
20160247668 | Szalay et al. | Aug 2016 | A1 |
20160284526 | Kenny et al. | Sep 2016 | A1 |
20160293395 | O'Brien et al. | Oct 2016 | A1 |
20160322960 | Taylor et al. | Nov 2016 | A1 |
20160336158 | Kovarik | Nov 2016 | A1 |
20170074283 | Manabe | Mar 2017 | A1 |
20170082585 | DeWitte et al. | Mar 2017 | A1 |
20170092477 | Giles et al. | Mar 2017 | A1 |
20170115383 | Iwama et al. | Apr 2017 | A1 |
20170168031 | Verenchikov | Jun 2017 | A1 |
20170169633 | Leung et al. | Jun 2017 | A1 |
20170190566 | Cramm et al. | Jul 2017 | A1 |
20170236699 | Ueda et al. | Aug 2017 | A1 |
20170287692 | Bateman et al. | Oct 2017 | A1 |
20170309465 | Jarrell | Oct 2017 | A1 |
20170372881 | Hoyes | Dec 2017 | A1 |
20180038838 | Karancsi | Feb 2018 | A1 |
20180053640 | Kurulugama et al. | Feb 2018 | A1 |
20180102241 | Gordon et al. | Apr 2018 | A1 |
20210151307 | Guna | May 2021 | A1 |
Number | Date | Country |
---|---|---|
103684817 | Mar 2014 | CN |
205705229 | Nov 2016 | CN |
206955673 | Feb 2018 | CN |
2817665 | Oct 1979 | DE |
102018105603 | May 2018 | DE |
0233784 | Aug 1987 | EP |
0317060 | May 1989 | EP |
0792091 | Aug 1997 | EP |
0919726 | Jun 1999 | EP |
1137044 | Sep 2001 | EP |
1393059 | Mar 2004 | EP |
1530229 | May 2005 | EP |
1597749 | Nov 2005 | EP |
1820203 | Aug 2007 | EP |
1830386 | Sep 2007 | EP |
1933365 | Jun 2008 | EP |
1933366 | Jun 2008 | EP |
1964153 | Sep 2008 | EP |
1166328 | Nov 2008 | EP |
1397822 | Mar 2010 | EP |
1884980 | Jun 2011 | EP |
1817789 | Nov 2011 | EP |
2431997 | Mar 2012 | EP |
2450941 | May 2012 | EP |
1825496 | Jun 2012 | EP |
2533042 | Dec 2012 | EP |
2567397 | Mar 2013 | EP |
2587521 | May 2013 | EP |
2092549 | Aug 2013 | EP |
2660850 | Nov 2013 | EP |
2633299 | Sep 2014 | EP |
2774172 | Sep 2014 | EP |
2797105 | Oct 2014 | EP |
2798657 | Nov 2014 | EP |
2806553 | Nov 2014 | EP |
1810314 | Apr 2015 | EP |
2866247 | Apr 2015 | EP |
1738398 | Jun 2015 | EP |
2038913 | Jul 2015 | EP |
2913914 | Sep 2015 | EP |
3005403 | Apr 2016 | EP |
3073509 | Sep 2016 | EP |
3084422 | Oct 2016 | EP |
3211781 | Aug 2017 | EP |
2033208 | Nov 2017 | EP |
3244439 | Nov 2017 | EP |
1789989 | Dec 2017 | EP |
2485243 | Mar 2018 | EP |
3404695 | Nov 2018 | EP |
1880406 | Jul 2019 | EP |
1593998 | Jul 1981 | GB |
2219432 | Dec 1989 | GB |
2329066 | Mar 1999 | GB |
2435712 | Sep 2007 | GB |
2440970 | Feb 2008 | GB |
2455171 | Jun 2009 | GB |
2473839 | Mar 2011 | GB |
2486584 | Jun 2012 | GB |
2489975 | Oct 2012 | GB |
2493072 | Jan 2013 | GB |
2515284 | Dec 2014 | GB |
2519853 | May 2015 | GB |
2533168 | Jun 2016 | GB |
2541808 | Mar 2017 | GB |
2552965 | Feb 2018 | GB |
S60180322 | Sep 1985 | JP |
H01121747 | May 1989 | JP |
H03233850 | Oct 1991 | JP |
H10233187 | Sep 1998 | JP |
H1125903 | Jan 1999 | JP |
H11230087 | Aug 1999 | JP |
2001050944 | Feb 2001 | JP |
2004226313 | Aug 2004 | JP |
2005285543 | Oct 2005 | JP |
2012043672 | Mar 2012 | JP |
2014022075 | Feb 2014 | JP |
2015121406 | Jul 2015 | JP |
9921212 | Apr 1999 | WO |
0185312 | Nov 2001 | WO |
02101382 | Dec 2002 | WO |
2004077488 | Sep 2004 | WO |
2006061625 | Jun 2006 | WO |
2006129083 | Dec 2006 | WO |
2007071991 | Jun 2007 | WO |
2007131146 | Nov 2007 | WO |
2008071923 | Jun 2008 | WO |
2009037483 | Mar 2009 | WO |
2010064321 | Jun 2010 | WO |
2011138669 | Nov 2011 | WO |
2012058632 | May 2012 | WO |
2013039772 | Mar 2013 | WO |
2013064842 | May 2013 | WO |
2013066881 | May 2013 | WO |
2013098642 | Jul 2013 | WO |
2014074822 | May 2014 | WO |
2014191750 | Dec 2014 | WO |
2014194023 | Dec 2014 | WO |
2014194172 | Dec 2014 | WO |
2015009478 | Jan 2015 | WO |
2015040386 | Mar 2015 | WO |
2015092501 | Jun 2015 | WO |
2017122276 | Jul 2017 | WO |
2018138814 | Aug 2018 | WO |
Entry |
---|
Examination Report under Section 18(3) for Application No. GB2020743.7, dated Jan. 28, 2022, 6 pages. |
Examination Report under Section 18(3) for Application No. GB1907719.7, dated Jul. 28, 2021, 9 pages. |
Parkes, S. SpaceWire User Guide, STAR-Dundee [online] 2012 [retrieved on Aug. 13, 2021], Retrieved from Internet URL: https://www.star-dundee.com/wp-content/star_uploads/general/SpaceWire-Users-Guide.pdf, 117 pages. |
SCIEX, “3200 Series of Instruments System User Guide” [online], published Apr. 2018, available from: https://sciex.com/content/dam/SCIEX/pdf/customer-docs/user-guide/3200-system-user-guide-en.pdf, 241 pages. |
Combined Search and Examination Report under Sections 17 and 18(3) for Application No. GB1808932.6, dated Nov. 21, 2018, 4 pages. |
Combined Search and Examination Report under Sections 17 and 18(3) for Application No. GB1808890.6, dated Nov. 28, 2018, 7 pages. |
Combined Search and Examination Report under Sections 17 and 18(3) for Application No. GB1808912.8, dated Nov. 30, 2018, 10 pages. |
Combined Search and Examination Report under Sections 17 and 18(3) for Application No. GB1808942.5, dated Dec. 3, 2018, 7 pages. |
Chernushevich, I. V., et al., “An introduction to quadrupole-time-of-flight mass spectrometry”, Journal of Mass Spectrometry, 36(8):849-65 (2001) Abstract only. |
Chernushevich, I.V., et al., “Charge state separation for protein applications using a quadrupole time-of-flight mass spectrometer”, Rapid Communications in Mass Spectrometry 17(13):1416-1424 (2003). Abstract only. |
Makarov, A. et al., “Performance evaluation of a hybrid linear ion trap/orbitrap mass spectrometer,” Analytical Chemistry, 78(7):2113-20 (2006). Abstract only. |
Combined Search and Examination Report under Sections 117 and 18(3) for Application No. GB1808948.2 dated Nov. 21, 2018, 7 pages. |
Combined Search and Examination Report under Sections 17 and 18(3) for Application No. GB1808893.0 dated Nov. 27, 2018, 8 pages. |
Combined Search and Examination Report under Sections 17 and 18(3) for Application No. GB1808936.7 dated Nov. 20, 2018, 10 pages. |
Combined Search and Examination Report under Sections 17 and 18(3) for Application No. GB1808892.2, dated Dec. 3, 2018, 6 pages. |
Combined Search and Examination Report under Sections 17 and 18(3) for Applicaton No. GB1808894.8 dated Dec. 3, 2018, 7 pages. |
Combined Search and Examination Report under Sections 17 and 18(3) for Application No. GB1808949.0 dated Oct. 31, 2018, 8 pages. |
Combined Search and Examination Report under Sections 17 and 18(3) for Application No. GB1907722.1 dated Jun. 28, 2019, 8 pages. |
Combined Search and Examination Report under Sections 17 and 18(3) for Application No. GB1808889.8 dated Nov. 30, 2018, 7 pages. |
International Search Report and Written Opinion for International application No. PCT/GB2019/051504, dated Jul. 23, 2019, 11 pages. |
Combined Search and Examination Report under Sections 17 and 18(3) for Application No. GB1818003.4, dated May 2, 2019, 6 pages. |
Invitation to pay additional fees and, where applicable, protest fee for PCT/GB2019/051508, dated Aug. 28, 2019. |
Author unknown, “Operating Manual and Programming Reference, Models RGA100, RGA200, and RGA300 Residual Gas Analyzer,” Stanford Research Systems Revision 1.8 (May 2009). |
Jungmann, J. H., et al., “An in-vacuum, pixelated detection system for mass spectrometric analysis and imaging of macromolecules,” International Journal of Mass Spectrometry, 341-342:34-44 (2013). |
Invitation to pay additional fees and, where applicable, protest fee for International application No. PCT/GB2019/051507, dated Aug. 20, 2019, 16 pages. |
Yang, C., and Hanley, L., “ChiMS: Open-source instrument control software platform on LabVIEW for imaging/depth profiling mass spectrometers,” Review of Scientific Instruments, 86:065106-1 through 065016-7 (2015). |
Invitation to pay additional fees and, where applicable, protest fee for International application No. PCT/GB2019/051506, dated Jul. 22, 2019, 13 pages. |
Invitation to pay addition al fees and, where applicable, protest fee for PCT/GB2019/051503, dated Jul. 25, 2019, 17 pages. |
International Search Report and Written Opinion for International application No. PCT/GB2019/051500, dated Aug. 5, 2019, 9 pages. |
Kozlov, B., et al., “Time-of-flight mass spectrometer for investigations of laser ablation,” ASMS Conference paper, Dallas, TX (May 1999). [Retrieved from the Internet URL: https//www.researchgate.net/publication/330202298_Time-of-flight_mass_spectrometer_for_investigations_of_laser_ablation]. Abstract. |
Shion, H., et al., “Towards Overcoming the Challenges of Implementing Accurate Mass MS for Routine Biotherapeutic Analysis” 2018 ASMS Prototype oa-TOF Abstract HYS Final. |
Shion, S., et al., “Towards Overcoming the Challenges of Implementing Accurate Mass MS for Routine Biotherapeutic Analysis” 2018 ASMS Prototype oa-TOF WP699 HYS Final Poster. |
Shion, H., et al., “A Fit-for-purpose Accurate Mass MS for Routine Biotherapeutic Analysis”, 2018 CASSS Mass Spec HYS Final Poster. |
Shion, H., et al., “A Fit-for-purpose Accurate Mass MS for Routine Biotherapeutic Analysis”, 2018 CASSS Mass Spec BioTof HYS Final, Abstract. |
Shion, H., et al., “Progress Towards Implementing Simple Time-of-flight Accurate Mass MS for Routine Biotherapeutic Analysis”, XXII (IMSC) International Mass Spectrometry Conference Florence, Italy (2018) Abstract. |
Shion, H., et al., “Progress Towards Implementing Simple Time-of-flight Accurate Mass MS for Routine Biotherapeutic Analysis”, XXII International Mass Spectrometry Conference Florence, Italy (2018) poster. |
Shion, H., et al., “Meeting the Challenges of Implementing Accurate-Mass Mass Spectrometry for Biotherapeutic Development in Regulated/non-Regulated Environments”, 2019 ASMS BioAccord Oral Session PowerPoint. |
Shion, H., et al., “Meeting the Challenges of Implementing Accurate-Mass Mass Spectrometry for Biotherapeutic Development in Regulated/non-Regulated Environments”, 2019 ASMS BioAccord Abstract. |
Shion, H., et al., “Meeting the Challenges of Implementing Accurate-Mass Mass Spectrometry for Biotherapeutic Development in Regulated/non-Regulated Environments” 2019 ATEurope BioAccord, Abstract. |
Shion, H., et al., “Meeting the Challenges of Implementing Accurate-Mass Mass Spectrometry for Biotherapeutic Development in Regulated/non-Regulated Environments” 2019 ATEurope BioAccord, Poster. |
Shion, H., et al., “Meeting the Challenges of Implementing Accurate-Mass Mass Spectrometry for biotherapeutic Development in Regulated/non-Regulated Environments”, 2019 BioPharma Analytical Summit BioAccord, abstract. |
Shion, H., et al., “Meeting the Challenges of Implementing Accurate-Mass Mass Spectrometry for Biotherapeutic Development in Regulated/non-Regulated Environments”, 2019 Bio Pharma Summit BioAccord, Poster. |
Shion, H., “Enabling Routine and Reproducible Biotherapeutic Analysis when Data Integrity Matters”, 2019 15th Annual PEGs Boston Waters BioAccord, PowerPoint 29 pages. |
Shion, H., “Enabling Routine and Reproducible Biotherapeutic Analysis when Data Integrity Matters”, 2019 15th Annual PEGs Boston Waters BioAccord, Abstract. |
Shion, H., et al., “Meeting the Challenges of Implementing Accurate-Mass Mass Spectrometry for Biotherapeutic Development in Regulated/non-Regulated Environments”, 2019 Pitt Con Bio Accord, Poster. |
Shion, H., et al., “Meeting the Challenges of Implementing Accurate-Mass Mass Spectrometry for Biotherapeutic Development in Regulated/non-Regulated Environments”, 2019 Pitt Con Bio Accord, Abstract. |
Combined S and E Report from IPO for GB Application No. 1907739.5, dated Nov. 27, 2019, 8 pages. |
International Search Report and Written Opinion for International application No. PCT/GB2019/051510, dated Aug. 29, 2019, 13 pages. |
Combined S and E Report from IPO for GB Application No. 1907735.3, dated Nov. 25, 2019, 7 pages. |
Combined S and E Report under Sections 17 and 18(3) for Application No. GB1907734.6, dated Oct. 31, 2019, 7 pages. |
International Search Report and Written Opinion for International Application No. PCT/GB2019/051498, dated Nov. 6, 2019, 21 pages. |
Combined Search and Examination Report under Sections 17 and 18(3) for Application No. GB1907719.7, dated Nov. 15, 2019, 11 pages. |
Author unknown, “Waters Xevo G2-S QTof Operators Overview and Maintenance Guide”, Feb. 11, 2013 (Feb. 11, 2013), XP55606374, Retrieved from the Internet: URL:https://www.waters.eom/webassets/cms/support/docs/xevo_g2-s_qtof_715003596rb.pdf [retrieved on Jul. 17, 2019]. |
International Search Report and Written Opinion for International application No. PCT/GB2019/051501, dated Sep. 25, 2019, 17 pages. |
Combined Search and Examination Report under Sections 17 and 18(3), for Application No. GB1907724 7, dated Sep. 25, 2019, 7 pages. |
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee for International application No. PCT/GB2019/051494, dated Sep. 19, 2019. |
Combined Search and Examination Report under Sections 17 and 18(3), dated Sep. 27, 2019, for Application No. GB1907736.1, 6 pages. |
Invitation to Pay Additional Fees and, Where Applicable, Protest Fees, for International application No. PCT/GB2019/051499, dated Sep. 4, 2019. |
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee, for International Application No. PCT/GB2019/051496, dated Aug. 29, 2019. |
Anonymous, “Time-of-flight mass spectrometry”, Wikipedia, Apr. 28, 2018 (Apr. 28, 2018), XP055614063, Retrieved from the Internet:URL:https://en.wikipedia.org/w/index.php title=Time-of-flight_mass_spectrometry oldid=838663844 [retrieved on Aug. 20, 2019]. |
Invitation to Pay Additional Fees and, Where Applicable, Protest Fees for International application No. PCT/GB2019/051497, dated Sep. 2, 2019. |
Combined Search and Examination Report under Sections 17 and 18(3) for Application No. GB1907745.2, dated Aug. 13, 2019, 7 pages. |
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee, for International application No. PCT/GB2019/051501, dated Jul. 29, 2019, 14 pages. |
International Search Report and Written Opinion for International application No. PCT/GB2019/051497, dated Nov. 5, 2019, 19 pages. |
International Search Report and Written Opinion for International application No. PCT/GB2019/051503, dated Sep. 25, 2019, 17 pages. |
International Search Report and Written Opinion for International application No. PCT/GB2019/051496, dated Oct. 23, 2019, 29 pages. |
International Search Report and Written Opinion for International application No. PCT/GB2019/051506, dated Sep. 25, 2019, 14 pages. |
International Search Report and Written Opinion for International application No. PCT/GB2019/051494, dated Nov. 18, 2019, 20 pages. |
International Search Report and Written Opinion for International application No. PCT/GB2019/051507, dated Oct. 15, 2019, 17 pages. |
International Search Report and Written Opinion for International application No. PCT/GB2019/051508, dated Oct. 23, 2019, 16 pages. |
International Search Report and Written Opinion for International application No. PCT/GB2019/051499, dated Nov. 5, 2019, 19 pages. |
Examination Report under Section 18(3) for Application No. GB1907739.5, dated Nov. 3, 2020, 5 pages. |
Combined Search and Examination Report under Sections 17 and 18(3), for Application No. GB2100898.2, dated Jun. 21, 2021, 7 pages. |
Combined Search and Examination Report under Sections 17 and 18(3), for Application No. GB2001530.1, dated Aug. 5, 2020, 7 pages. |
Thermo Fisher Scientific, Inc, Feb. 2015, Orbitrap Fusion Hardware Manual [online]. Retrieved from Internet URL: http://www.unitylabservices.eu/content/dam/tfs/ATG/CMD/cmddocuments/oper/oper/ms/lc-ms/sys/Man-80000-97016-Orbitrap-Fusion-Hardware-Man8000097016-A-EN.pdf, 122 pages. |
Shion, H., et al., “Meeting the Challenges of Implementing Accurate-Mass Mass Spectrometry for Biotherapeutic Development in Regulated/non-Regulated Environments”, 2019 BioPharma Analytical Summit BioAccord Abstract. ASMS MS-in-QC, PowerPoint 24 pages. |
International Preliminary Report on Patentability for International application No. PCT/GB2019/051510, dated Dec. 1, 2020, 7 pages. |
Examination Report under Section 18(3) for Application No. GB1907722.1, dated Oct. 26, 2021, 4 pages. |
Number | Date | Country | |
---|---|---|---|
20190371583 A1 | Dec 2019 | US |
Number | Date | Country | |
---|---|---|---|
62678413 | May 2018 | US |